-
Product Insights
Primary Sjogren’s Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Primary Sjogren's Syndrome - Drugs In Development, 2023’, provides an overview of the Primary Sjogren's Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Sjogren's Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.